Fate Therapeutics Inc (FATE) Stock: Soaring On Financing And EU Approval

Fate Therapeutics Inc (NASDAQ:FATE) announced on Tuesday that it has entered into a definitive securities purchase agreement with certain institutional and other accredited investors...

Keep Reading →